1. Home
  2. AUDC vs TRDA Comparison

AUDC vs TRDA Comparison

Compare AUDC & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AudioCodes Ltd.

AUDC

AudioCodes Ltd.

HOLD

Current Price

$9.12

Market Cap

245.9M

Sector

Utilities

ML Signal

HOLD

TRDA

Entrada Therapeutics Inc.

HOLD

Current Price

$6.49

Market Cap

254.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUDC
TRDA
Founded
1992
2016
Country
Israel
United States
Employees
N/A
152
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
245.9M
254.7M
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
AUDC
TRDA
Price
$9.12
$6.49
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$12.50
$21.00
AVG Volume (30 Days)
109.8K
603.9K
Earning Date
05-05-2026
05-08-2026
Dividend Yield
4.54%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$25,421,000.00
Revenue This Year
$4.24
$39.97
Revenue Next Year
$2.18
$50.80
P/E Ratio
$23.06
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.95
$4.93
52 Week High
$11.48
$16.45

Technical Indicators

Market Signals
Indicator
AUDC
TRDA
Relative Strength Index (RSI) 56.71 32.62
Support Level $8.46 $5.58
Resistance Level $9.82 $6.90
Average True Range (ATR) 0.33 0.81
MACD 0.01 -0.29
Stochastic Oscillator 94.55 8.23

Price Performance

Historical Comparison
AUDC
TRDA

About AUDC AudioCodes Ltd.

AudioCodes Ltd provides voice communications solutions for enterprises, contact centers, and service providers, including voice infrastructure, cloud-based platforms, and Voice AI applications. Its AudioCodes Live Platform is a cloud-based service delivery platform that enables provisioning, management, and operation of voice and AI-based communication services, including PSTN connectivity and integration with platforms such as Microsoft Teams, Webex Calling, and Zoom Phone. The company's solutions are organized into three layers: voice infrastructure and devices, cloud-based platforms, and Voice AI applications for contact center and productivity use cases. It also offers management tools such as One Voice Operations Center (OVOC), Device Manager, and AudioCodes Routing Manager (ARM).

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

Share on Social Networks: